Press Release

NeoGenomics First to Partner with Biomarker Collaborative and Deliver Patient Resources Along with Oncology Testing Results

NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR™ MRD and InVisionFirst®-Lung Assays at the ESMO Congress 2021

NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021

NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences

NeoGenomics To Participate In The Bank of America 2021 Health Care Conference

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients